Cardiff Oncology, Inc. (CRDF)
2.39
-0.08
(-3.43%)
USD |
NASDAQ |
Dec 12, 16:00
2.34
-0.05
(-2.09%)
After-Hours: 20:00
Cardiff Oncology Profit Margin (Quarterly): -9.38K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -- |
| Curis, Inc. | -243.4% |
| AIM ImmunoTech, Inc. | -12.63K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -81.17% |
| Return on Assets | -65.58% |
| Return on Invested Capital | -79.44% |
| Gross Profit Margin (Quarterly) | -86.67% |
| Operating Margin (Quarterly) | -9.98K% |
| Return on Net Operating Assets | -1.97K% |